Effect of raloxifene after recombinant teriparatide [hPTH(1–34)] treatment in postmenopausal women with osteoporosis

被引：0
|
作者：
S. Adami
J. San Martin
M. Muñoz-Torres
M. J. Econs
L. Xie
G. P. Dalsky
M. McClung
D. Felsenberg
J. P. Brown
M. L. Brandi
A. Sipos
机构：
[1] University of Verona,Riabilitazione Reumatologica
[2] Eli Lilly and Company,Lilly Research Laboratories
[3] Global Development Leader Bone Therapeutic Area A,Unidad de Metabolismo Óseo
[4] Hospital Universitario San Cecilio,Division of Endocrinology & Metabolism
[5] Indiana University School of Medicine,undefined
[6] Oregon Osteoporosis Center,undefined
[7] Charité – Universitätsmedizin,undefined
[8] Campus Benjamin Franklin,undefined
[9] Groupe de recherche en rhumatologie et maladies osseuses,undefined
[10] Ospedale Di Careggi,undefined
[11] University of Florence,undefined
来源：
Osteoporosis International | 2008年 / 19卷
关键词：
Antiresorptive therapy; Bone mineral density; Raloxifene; Teriparatide; Treatment discontinuation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：87 / 94
页数：7
相关论文
共 50 条
  • [21] Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene
    Meunier, PJ
    Vignot, E
    Garnero, P
    Confavreux, E
    Paris, E
    Liu-Leage, S
    Sarkar, S
    Liu, T
    Wong, M
    Draper, MW
    [J]. OSTEOPOROSIS INTERNATIONAL, 1999, 10 (04) : 330 - 336
  • [22] Effect of raloxifene hydrochloride on postmenopausal Japanese women with osteoporosis.
    Morii, H
    Orimo, H
    Taketani, Y
    Ishii, J
    Inoue, T
    Fujita, T
    Ohashi, Y
    Huster, WJ
    Lakshmanan, M
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : T588 - T588
  • [23] Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis
    Ensrud, K
    Genazzani, AR
    Geiger, MJ
    McNabb, M
    Dowsett, SA
    Cox, DA
    Barrett-Connor, E
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2006, 97 (04): : 520 - 527
  • [24] Assessment of adherence to treatment of postmenopausal osteoporosis with raloxifene and/or alfacalcidol in postmenopausal Japanese women
    Gorai, Itsuo
    Tanaka, Yaku
    Hattori, Shin
    Iwaoki, Yasuhisa
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2010, 28 (02) : 176 - 184
  • [25] Assessment of adherence to treatment of postmenopausal osteoporosis with raloxifene and/or alfacalcidol in postmenopausal Japanese women
    Itsuo Gorai
    Yaku Tanaka
    Shin Hattori
    Yasuhisa Iwaoki
    [J]. Journal of Bone and Mineral Metabolism, 2010, 28 : 176 - 184
  • [26] Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis
    Nakamura, T
    Liu, J
    Morii, H
    Huang, Q
    Zhu, H
    Qu, Y
    Hamaya, E
    Thiebaud, D
    [J]. BONE, 2005, 36 : S430 - S431
  • [27] Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis
    Nakamura, Toshitaka
    Liu, Jian Li
    Morii, Hirotoshi
    Huang, Qi Ren
    Zhu, Han Min
    Qu, Yongming
    Hamaya, Etsuro
    Thiebaud, Daniel
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2006, 24 (05) : 414 - 418
  • [28] Effect of raloxifene on clinical fractures in Asian women with postmenopausal osteoporosis
    Toshitaka Nakamura
    Jian Li Liu
    Hirotoshi Morii
    Qi Ren Huang
    Han Min Zhu
    Yongming Qu
    Etsuro Hamaya
    Daniel Thiebaud
    [J]. Journal of Bone and Mineral Metabolism, 2006, 24 : 414 - 418
  • [29] Intranasal delivery of recombinant human parathyroid hormone [hPTH (1-34)], teriparatide in rats
    Agu, RU
    Valiveti, S
    Earles, DC
    Klausner, M
    Hayden, PJ
    Wermeling, DP
    Stinchcomb, AL
    [J]. ENDOCRINE RESEARCH, 2004, 30 (03) : 455 - 467
  • [30] Effect of raloxifene on sexual function in older postmenopausal women with osteoporosis
    Modugno, F
    Ness, RB
    Ewing, S
    Cauley, JA
    [J]. OBSTETRICS AND GYNECOLOGY, 2003, 101 (02): : 353 - 361
12345